Abatacept for the treatment of systemic lupus erythematosus.

Abstract

INTRODUCTION Due to improvements in our understanding of the pathogenesis of systemic lupus erythematosus (SLE), several target drugs have been and are being developed. One of the possible targets in SLE is co-stimulation between antigen-presenting cells and T cells. Abatacept is a co-stimulation moderator approved for the treatment of several autoimmune… (More)
DOI: 10.1517/13543784.2016.1154943

Topics

1 Figure or Table

Cite this paper

@article{PimentelQuiroz2016AbataceptFT, title={Abatacept for the treatment of systemic lupus erythematosus.}, author={Victor Rom{\'a}n Pimentel-Quiroz and Manuel F Ugarte-Gil and Graciela S Alarc{\'o}n}, journal={Expert opinion on investigational drugs}, year={2016}, volume={25 4}, pages={493-9} }